TPG Biotech

About

Portfolio · 1

Nutrinia

Neonatal Gastrointestinal Treatment

1 round $30.0M committed Latest: 2016-08

Investment activity

Funds · 1

• Life Science Innovations — $580M Aug 2024

Q&A

What is TPG Biotech's primary investment focus?

TPG Biotech primarily focuses its investments within the Health Tech & Life Sciences sector, with all of its identified portfolio companies operating in this area.

What is the most recent fund raised by TPG Biotech?

TPG Biotech raised the "Life Science Innovations" fund, amounting to $580M, in August 2024.

Can you name some of TPG Biotech's portfolio companies?

TPG Biotech's portfolio includes Azura Ophthalmics, which develops ophthalmic keratolytics, and Nutrinia, focused on neonatal gastrointestinal treatment.

What was the latest funding round TPG Biotech participated in?

TPG Biotech participated in a Series C funding round for Azura Ophthalmics in October 2020, which raised $37.2M.

What is TPG Biotech's investment stage preference?

TPG Biotech has participated in various stages, including a Series B round in August 2016, a Series C round in October 2017, and a Series D round in October 2020.

When was TPG Biotech founded?

TPG Biotech was founded in 1992.